Two US healthcare companies have brought hope in the race to fight coronavirus, with Johnson & Johnson announcing a potential vaccine that could be available early next year and Abbott Laboratories launching a rapid test.
Johnson & Johnson said it had discovered a potential vaccine candidate and was teaming up with the US government to invest $1 billion (€900 million) in its development, expecting to start testing in humans by September. Shares in the world’s largest healthcare company rose 5.8 per cent to $130.17.
Abbott is launching a test that can take as little as five minutes and can be run on a portable machine the size of a toaster. Shares in Abbott jumped 8.7 per cent to $81.07.
For more details irishtimes.com
